+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID04557995

Evaluating Erythrocytapheresis Combined with Standard Care in Treating Chronic Mountain Sickness

Led by Third Military Medical University · Updated on 2026-08-25

112

Participants Needed

1

Research Sites

39 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effectiveness and safety of erythrocytapheresis in people with Chronic Mountain Sickness CMS. This condition affects residents living at high altitudes, and the study aims to compare outcomes between those receiving erythrocytapheresis plus standard care and those receiving standard care alone. The trial focuses on how well this blood cell removal procedure works as a method to reduce hematocrit levels and improve symptoms. Participants will be randomly assigned to one of two groups. The intervention group will receive erythrocytapheresis, which involves removing a set amount of red blood cells using a machine, while their plasma and other blood components are returned to maintain blood volume. Both groups will continue with standard care, including oxygen therapy and basic medical management. Clinical assessments will be conducted shortly after treatment and during follow-up to compare symptoms and physical function. Throughout the study, participants will undergo evaluations such as symptom scoring for CMS, the Incremental Shuttle Walk Test to measure exercise capacity, blood oxygen levels, and monitoring for any complications from the procedure. These assessments will occur 48 to 72 hours after erythrocytapheresis or prior to discharge for the standard care group, and then periodically during follow-up. The research team will use this data to understand the potential benefits and safety of erythrocytapheresis over time.

CONDITIONS

Brief Title

Erythrocytapheresis for Chronic Mountain Sickness

Research Team

J

Jieru Guo

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here